Anglais

Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.

18 Formulaires  
  1. StudyEvent: SEV1
    1. Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    2. Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    3. Sample ID, analyte type, and tumor status of a participant with uterine cervical neoplasm and involved in the "The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer Cell Line" project.
    4. Sample ID, analyte type, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "The Genomic and Transcriptomic Landscape of a HeLa Cell Line" project.
    5. Subject ID, birthplace, sex, and race of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    6. Sample ID and trace ID of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    7. Sample ID, body site where sample was collected, analyte type, histological type and sequences center of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    8. Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary or metastatic tumor, sequencing center of participant with uterine cervical adenocarcinoma and involved in the "High Resolution Maps of the HeLa 3D Genome Using Hi-C" project.
    9. Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, primary or metastatic tumor, primary tumor location, and sequencing center of participant with uterine cervical adenocarcinoma and involved in the "The Heterogeneity Study of HeLa S3 Cells Based on Full-Length Single-Cell RNA-seq" project.
    10. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Construction of Thousands of Single Cell Genome Sequencing Libraries Using Combinatorial Indexing" project.
    11. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.
    12. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of participants uterine cervical neoplasm and involved in the "Identification of G-quadruplex Clusters by High-throughput Sequencing of Whole-genome Amplified Products with a G-quadruplex Ligand" project.
    13. Sample ID and GEO accession of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    14. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, and sequencing center of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    15. Sample ID, experimental conditions, tumor sample status, type of sample data, and source where sample was sequenced of a participant with uterine cervical neoplasm and involved in the "Examination of engineered LINE-1 Integration events in HeLa cells" project.
    16. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of a participant with uterine cervical neoplasm and involved in the "RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition" project.
    17. Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, primary or metastatic tumor, primary tumor location, and sequencing center of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    18. Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
pht003438
Description

pht003438

Alias
UMLS CUI [1,1]
C3846158
Data use consent
Description

CONSENT

Type de données

text

Alias
UMLS CUI [1,1]
C0021430
Subject source
Description

SUBJECT_SOURCE

Type de données

text

Alias
UMLS CUI [1,1]
C0449416
Source subject ID
Description

SOURCE_SUBJECT_ID

Type de données

text

Alias
UMLS CUI [1,1]
C2348585
UMLS CUI [1,2]
C0449416
Affection status
Description

AFFECTION_STATUS

Type de données

text

Alias
UMLS CUI [1,1]
C3274646
Subject ID
Description

SUBJECT_ID

Type de données

text

Alias
UMLS CUI [1,1]
C2348585
Retour au début de la page

Similar models

Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.

18 Formulaires
  1. StudyEvent: SEV1
    1. Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    2. Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    3. Sample ID, analyte type, and tumor status of a participant with uterine cervical neoplasm and involved in the "The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer Cell Line" project.
    4. Sample ID, analyte type, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "The Genomic and Transcriptomic Landscape of a HeLa Cell Line" project.
    5. Subject ID, birthplace, sex, and race of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    6. Sample ID and trace ID of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    7. Sample ID, body site where sample was collected, analyte type, histological type and sequences center of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    8. Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary or metastatic tumor, sequencing center of participant with uterine cervical adenocarcinoma and involved in the "High Resolution Maps of the HeLa 3D Genome Using Hi-C" project.
    9. Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, primary or metastatic tumor, primary tumor location, and sequencing center of participant with uterine cervical adenocarcinoma and involved in the "The Heterogeneity Study of HeLa S3 Cells Based on Full-Length Single-Cell RNA-seq" project.
    10. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Construction of Thousands of Single Cell Genome Sequencing Libraries Using Combinatorial Indexing" project.
    11. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.
    12. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of participants uterine cervical neoplasm and involved in the "Identification of G-quadruplex Clusters by High-throughput Sequencing of Whole-genome Amplified Products with a G-quadruplex Ligand" project.
    13. Sample ID and GEO accession of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    14. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, and sequencing center of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    15. Sample ID, experimental conditions, tumor sample status, type of sample data, and source where sample was sequenced of a participant with uterine cervical neoplasm and involved in the "Examination of engineered LINE-1 Integration events in HeLa cells" project.
    16. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of a participant with uterine cervical neoplasm and involved in the "RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition" project.
    17. Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, primary or metastatic tumor, primary tumor location, and sequencing center of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    18. Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
pht003438
C3846158 (UMLS CUI [1,1])
Item
Data use consent
text
C0021430 (UMLS CUI [1,1])
CONSENT
Code List
Data use consent
CL Item
Health/Medical/Biomedical (HMB) (1)
SUBJECT_SOURCE
Item
Subject source
text
C0449416 (UMLS CUI [1,1])
SOURCE_SUBJECT_ID
Item
Source subject ID
text
C2348585 (UMLS CUI [1,1])
C0449416 (UMLS CUI [1,2])
Item
Affection status
text
C3274646 (UMLS CUI [1,1])
AFFECTION_STATUS
Code List
Affection status
CL Item
Case (1)
C3274647 (UMLS CUI [1,1])
SUBJECT_ID
Item
Subject ID
text
C2348585 (UMLS CUI [1,1])
Retour au début de la page